oncology

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

The collaboration will increase the use cases for healthcare professionals to create care protocols and new treatments in oncology and promote precision medicine.

The alliance combines ConcertAI's data platform with Bayer's scientific and AI expertise.

Notable partners with CityMD, and Bamboo Health join forces with Ohio to strengthen its prescription drug monitoring system.  

DeepScribe will be the first ambient AI partner for Flatiron Health, and will integrate with Flatiron's OncoEMR.   

Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe) and cohost of CancerX, highlights ONC's annual meeting and how data with interoperability, privacy and security protections can fundamentally change oncology outcomes.  

Rutherford Health Chief Medical Officer Karol Sikora highlights the most pressing needs in cancer treatment today and how he envisages treatment decision-making in the next decade.

Bradford Power, founder of Reengineering Cancer Treatment and an author focused on process improvement, speaks from experience on why oncology treatment needs to become more personalized.